https://doi.org/10.1016/j.jacc.2006.05.057
Z
Zhaoming Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
235
Papers
4.1K
Citations
34
h-index
104
i10-index
Zhaoming Li is an academic researcher from Hebei University of Technology. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & Immune Cell Function and Interaction. The author has an h-index of 34, co-authored 200 publications.
ORCID: 0000-0002-2876-5182Papers by this author
worksNeuregulin-1/erbB-Activation Improves Cardiac Function and Survival in Models of Ischemic, Dilated, and Viral Cardiomyopathy
2006 · Journal of the American College of Cardiology · 273 citations
Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
2021 · Frontiers in Oncology · 90 citations
https://doi.org/10.3389/fonc.2021.731175
Self-emulsifying drug delivery system and the applications in herbal drugs
2013 · Drug Delivery · 77 citations
https://doi.org/10.3109/10717544.2013.861659
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma
2019 · Nature Communications · 34 citations
https://doi.org/10.1038/s41467-019-12032-9
The clinical features and prognosis of 100 AIDS-related lymphoma cases
2019 · Scientific Reports · 31 citations
https://doi.org/10.1038/s41598-019-41869-9
Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase
2017 · Scientific Reports · 30 citations
https://doi.org/10.1038/srep41057
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat